发明名称 ORGANIC COMPOUNDS
摘要 The invention relates to 3,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (= disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,5-substituted piperidine compound, a method for the manufacture of a 3, 5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis. The preferred compounds (which can also be present as salts) have the formula I wherein R1 , R2, T, R3 and R4 are as defined in the specification.
申请公布号 WO2007006534(A2) 申请公布日期 2007.01.18
申请号 WO2006EP06733 申请日期 2006.07.10
申请人 NOVARTIS AG;NOVARTIS PHARMA GMBH;BREITENSTEIN, WERNER;EHRHARDT, CLAUS;MAIBAUM, JUERGEN, KLAUS;OSTERMANN, NILS;ZIMMERMANN, JUERG;MASUYA, KEIICHI;KONISHI, KAZUHIDE;YOKOKAWA, FUMIAKI;KANAZAWA, TAKANORI;JACOBY, EDGAR;MARZINZIK, ANDREAS;GROSCHE, PHILIPP;KAWAKAMI, SHIMPEI 发明人 BREITENSTEIN, WERNER;EHRHARDT, CLAUS;MAIBAUM, JUERGEN, KLAUS;OSTERMANN, NILS;ZIMMERMANN, JUERG;MASUYA, KEIICHI;KONISHI, KAZUHIDE;YOKOKAWA, FUMIAKI;KANAZAWA, TAKANORI;JACOBY, EDGAR;MARZINZIK, ANDREAS;GROSCHE, PHILIPP;KAWAKAMI, SHIMPEI
分类号 C07D211/56;C07D403/12;C07D403/14;C07D409/12;C07D413/12;C07D413/14;C07D417/12 主分类号 C07D211/56
代理机构 代理人
主权项
地址